METRO is a multicentre prospective cohort study exploring the outcomes of patients under the age of 55 with a meniscal tear
The aims of this study are to document the symptoms, imaging findings (MRI) and current NHS treatment of people who present with a meniscal tear under the age of 55, and to determine whether symptoms or MRI findings relate to the outcome of treatment.
- Presence of a MRI confirmed meniscal tear
- Age between 18-55
- ACL or other major knee ligament injury. This does not include previous unrelated healed MCL tear or a meniscal root tear (which is considered a type of meniscal tear in this study)
- Associated intra-articular fracture of the tibial plateau or femur. Previous fractures not thought to be related to the tear are not an exclusion criteria for the study.
- Previous knee surgery
- Previous entry into the present study (i.e the other knee)
- Unable to undertake study procedures
Data collection and Outcomes:
- Baseline data: mechanism of injury, symptoms, MRI findings and PROMs
- Primary outcome: Western Ontario Meniscal Evaluation Tool (WOMET) at 12 months
- Secondary outcomes: KOOS4, EQ5D and Patient global impression of change score at 3,6 and 12 months.